Literature DB >> 32606373

Excess tau PET ligand retention in elderly patients with major depressive disorder.

Sho Moriguchi1,2,3, Keisuke Takahata4,5, Hitoshi Shimada4, Manabu Kubota4, Soichiro Kitamura4, Yasuyuki Kimura4, Kenji Tagai4, Ryosuke Tarumi5, Hajime Tabuchi5, Jeffrey H Meyer6, Masaru Mimura5, Kazunori Kawamura4, Ming-Rong Zhang4, Shigeo Murayama7, Tetsuya Suhara4, Makoto Higuchi4.   

Abstract

Depression is one of the common psychiatric disorders in old age. Major depressive disorder (MDD) has been identified as a risk factor or prodrome for neurodegenerative dementias, suggesting neuropathological overlaps and a continuum between MDD and neurodegenerative disorders. In this study, we examined tau and amyloid-β (Aβ) accumulations in the brains of MDD and healthy controls using positron emission tomography (PET) to explore pathological substrates of this illness. Twenty MDD and twenty age-matched, healthy controls were examined by PET with a tau radioligand, [11C]PBB3, and an Aβ radioligand, [11C]PiB. Radioligand retentions were quantified as a standardized uptake value ratio (SUVR). We also assessed clinical manifestations of the patients using the 17-item Hamilton Depression Scale, the Geriatric Depression Scale, and psychotic symptoms. Mean cortical [11C]PBB3 SUVRs in MDD patients were significantly higher than those of healthy controls. These values were higher in MDD patients with psychotic symptoms than in those without any. The present findings indicate that tau depositions may underlie MDD, and especially in patients with psychotic symptoms. PET detection of tau accumulations may provide mechanistic insights into neuronal dysfunctions in these cases and could serve as predictions of their clinical consequences.
© 2020. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32606373     DOI: 10.1038/s41380-020-0766-9

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  43 in total

1.  Staging of argyrophilic grains: an age-associated tauopathy.

Authors:  Yuko Saito; Nyoka N Ruberu; Motoji Sawabe; Tomio Arai; Noriko Tanaka; Yukio Kakuta; Hiroshi Yamanouchi; Shigeo Murayama
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

2.  Late life depression.

Authors:  C G Gottfries
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

Review 3.  Depression and risk of developing dementia.

Authors:  Amy L Byers; Kristine Yaffe
Journal:  Nat Rev Neurol       Date:  2011-05-03       Impact factor: 42.937

4.  The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease.

Authors:  Josh D Woolley; Baber K Khan; Nikhil K Murthy; Bruce L Miller; Katherine P Rankin
Journal:  J Clin Psychiatry       Date:  2011-02       Impact factor: 4.384

Review 5.  Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis.

Authors:  Daniela Galimberti; Bernardo Dell'Osso; A Carlo Altamura; Elio Scarpini
Journal:  Biol Psychiatry       Date:  2015-04-08       Impact factor: 13.382

Review 6.  The overlap of symptomatic dimensions between frontotemporal dementia and several psychiatric disorders that appear in late adulthood.

Authors:  Mariangeles Pose; Marcelo Cetkovich; Ezequiel Gleichgerrcht; Agustin Ibáñez; Teresa Torralva; Facundo Manes
Journal:  Int Rev Psychiatry       Date:  2013-04

7.  Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.

Authors:  Marisa Srivareerat; Trinh T Tran; Karem H Alzoubi; Karim A Alkadhi
Journal:  Biol Psychiatry       Date:  2008-10-11       Impact factor: 13.382

8.  The prognosis of depression in old age.

Authors:  E Murphy
Journal:  Br J Psychiatry       Date:  1983-02       Impact factor: 9.319

Review 9.  Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.

Authors:  Juan Carlos Polanco; Chuanzhou Li; Liviu-Gabriel Bodea; Ramon Martinez-Marmol; Frederic A Meunier; Jürgen Götz
Journal:  Nat Rev Neurol       Date:  2017-12-15       Impact factor: 42.937

Review 10.  Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies.

Authors:  Breno S Diniz; Meryl A Butters; Steven M Albert; Mary Amanda Dew; Charles F Reynolds
Journal:  Br J Psychiatry       Date:  2013-05       Impact factor: 9.319

View more
  2 in total

1.  Kampo formulas alleviate aging-related emotional disturbances and neuroinflammation in male senescence-accelerated mouse prone 8 mice.

Authors:  Naoki Ito; Akiko Maruko; Kenshiro Oshima; Masaaki Yoshida; Kengo Honma; Chika Sugiyama; Takayuki Nagai; Yoshinori Kobayashi; Hiroshi Odaguchi; Norihiro Okada
Journal:  Aging (Albany NY)       Date:  2022-01-03       Impact factor: 5.682

2.  Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer's Disease Psychosis.

Authors:  J J Gomar; G Tan; J Halpern; M L Gordon; B Greenwald; J Koppel
Journal:  Transl Psychiatry       Date:  2022-02-26       Impact factor: 6.222

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.